Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Science Advances|April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicineLorenzo Federico, Zechen Chong, Dong Zhang, et al.Science Translational Medicine|June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancersChaoyang Sun, Yong Fang, Jun Yin, et al.Cancer Research|January 7, 2026
Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast CancerSarah K Herzog, Jessica H Stevens, Guowei Gu, et al.Nature Communications|January 3, 2024
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA responseMei Zhao, Tianxiao Wang, Frederico O Gleber-Netto, et al.Cancer Cell|February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerDaniel J McGrail, Jeannine Garnett, Jun Yin, et al.Cancer Cell|June 12, 2019
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining EfficacyYong Fang, Daniel J McGrail, Chaoyang Sun, et al.Journal for Immunotherapy of Cancer|February 3, 2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytesParin Shah, Marie-Andrée Forget, Meredith L Frank, et al.JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.Pageof 9